Tim Weinheimer's blog

Tim Weinheimer's picture

The "New" Patient Journey: How Mobile is Transforming Healthcare


Mobile is changing healthcare marketing and [[wysiwyg_imageupload:213:]]
communications in three major ways. First, it's transformed the creation of content and the way communicators determine what's relevant and to whom. Secondly, it's changed how communicators create and inhabit platforms —specifically to engage and converse with people and patients. Finally, mobile has shifted communicators’ views of what’s actually valuable to a patient long before the doctor actually take his or her temperature!

Patient engagement has gone from a triage to a “four-age”: Sixty percent of U.S. patients are using their smart device while waiting for an appointment and even during the doctor visit. The classic teachable moment has gone from a party of three with the doctor, patient and nurse to a party of four that now includes a mobile device. Clearly knowing and understanding your mobile patient’s profile is job one. Read full post »

Tim Weinheimer's picture

Top Three Tips for Meeting FDA’s New Interactive Promotional Media Guidelines


With the FDA release of its latest guidelines on[[wysiwyg_imageupload:170:]]
the use of new interactive promotional media there are new opportunities for PR professionals. The FDA’s new report is titled “Guidance for Industry Fulfilling Regulatory Requirements for Postmarketing Submissions of Interactive Promotional Media for Prescription Human and Animal Drugs and Biologics” and within the report there are 3 opportunities for PR professionals related to managing online influencer relationships and FDA-approved content optimization.

The Top 3 Tips:

“Representatives” or agencies can squarely sharpen their communications outreach in 2014 in response to these new guidelines by taking the following steps to digitally optimize their clients’ campaigns for success.


1.    Subscribe to influencer database tools and software. Read full post »

Tim Weinheimer's picture

Is Your Web Domain in Order for Responding to Unsolicited Requests?


The process of prescribing, dispensing and using [[wysiwyg_imageupload:111:]]
medications leaves little room for medical errors when the health of the consumer is at stake.

The same holds true in making sure there is no room for error in “dispensing” prescription drug and medical device information on your web sites. The new FDA guidelines present the opportunity to ensure your customers can and will find readily accessible and accurate off-label information across your company and branded web properties. With the new FDA guidance for responding to unsolicited requests for off-label information, it may be time for a cross-domain audit of your web properties – an audit to simply ensure such off-label information is current and meeting FDA requirements.

Per the FDA recommendations, a firm’s contact and disclosure information, a public response should include a mechanism for providing readily accessible current FDA-required labelling, if any, for the product (e.g., FDA-approved package insert and, if the response is for a consumer, FDA-approved patient labelling or, for new animal drugs, FDA-approved client information sheet. Read full post »

In: Digital & Social Media  /   filed under: FDA | Social Media | website
Tim Weinheimer's picture

Wait Not For FDA Social Media Guidelines


[[wysiwyg_imageupload:59:]]Pharma marketers have become quite accustomed to rules, limitations and delays. Adding to this complexity and quandary is the further delay of the FDA social media guidelines. In fact, according to a recent post on John Mack’s Pharma Marketing Blog, it appears that the FDA has dropped social media from its 2011 Guidance Agenda.  But wait not for those guidelines! Successful social media in the pharma and healthcare space simply requires more careful planning with a dose of persistence on initiatives you should be doing already. And if you’re not already doing it, start today! Read full post »